Skip to Main Content

Author Details

Michel Komajda
Saint Joseph Hospital, Paris-Sorbonne University
1978
459
92
PMIDPaper TitleJournal TitlePublished Year
36823770Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptions.Eur J Heart Fail2023
37558385Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF.JACC Heart Fail2023
37661847Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry.Eur J Heart Fail2023
37677914[Introduction of treatments for heart failure and reduced ejection fraction under 50 % : In-hospital optimization using an algorithmic approach].Ann Cardiol Angeiol (Paris)2023
37427483Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial).ESC Heart Fail2023
37092340Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.Eur J Heart Fail2023
36881400Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial.JACC Heart Fail2023
35940973[Impact of Home Return Assistance Service in Heart Failure (PRADO-IC) on the one year re-hospitalisation and mortality in a heart failure hospitalized population of patients].Ann Cardiol Angeiol (Paris)2022
35653582Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry.Eur J Prev Cardiol2022
33301080Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.Clin Res Cardiol2021
33569926Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry.ESC Heart Fail2021
33677556Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23.Eur Heart J2021
33549560The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials.JACC Heart Fail2021
34517970Données épidémiologiques d'une cohorte de patients hospitalisés pour insuffisance cardiaque. ÿtude mono-centrique sur 3 ans. Comparaison avec les données régionales.Ann Cardiol Angeiol (Paris)2021
33966083Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry.Eur J Prev Cardiol2021
34152828Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.Ann Intern Med2021
33200892Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.N Engl J Med2021
33118250Asymptomatic left ventricular dysfunction in patients with type 2 diabetes free of cardiovascular disease and its relationship with clinical characteristics: The DIACAR cohort study.Diabetes Obes Metab2021
33081531Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.Circulation2021
31056691Global and regional echocardiographic strain to assess the early phase of hypertrophic cardiomyopathy due to sarcomeric mutations.Eur Heart J Cardiovasc Imaging2020
31816162European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure.Eur J Heart Fail2020
32059048Correction: Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy.PLoS One2020
32580655Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study.Circ Heart Fail2020
32215700Covariate adjusted reanalysis of the I-Preserve trial.Clin Res Cardiol2020
31350276Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.Heart2020
30361818Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey.Clin Res Cardiol2019
31813280Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.Circ Heart Fail2019
31271255Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.Eur J Heart Fail2019
31370950Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.J Am Coll Cardiol2019
31591826Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.ESC Heart Fail2019
30981744Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.JACC Heart Fail2019
30933403Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.Eur J Heart Fail2019
29027329Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.Eur J Heart Fail2018
29806165Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.Eur J Heart Fail2018
29520964Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail2018
29632676Role of ivabradine in management of stable angina in patients with different clinical profiles.Open Heart2018
29338315The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up.Eur J Prev Cardiol2018
29102365Pregnancy in women with a cardiomyopathy: Outcomes and predictors from a retrospective cohort.Arch Cardiovasc Dis2018
27317843Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.J Card Fail2017
30512669Pharmacological management of chronic heart failureRev Prat2017
30512668Management of acute heart failureRev Prat2017
28463464Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.Eur J Heart Fail2017
28462519Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.Eur J Heart Fail2017
28139302Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.Int J Cardiol2017
28296976Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy.PLoS One2017
28426886Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.Eur Heart J2017
28393439Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.Eur J Heart Fail2017
29387466Quality of Physician Adherence to Guideline Recommendations for Life-saving Treatment in Heart Failure: an International Survey.Card Fail Rev2017
28627045Heart rate and its reduction in chronic heart failure and beyond.Eur J Heart Fail2017
28643218Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes.Cardiovasc Drugs Ther2017
  • 1 - 50 of 459

Recommended Authors

Marat Fudim
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 16
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 3
John L Jefferies
University of Tennessee Health Sciences Centre
Career Start Year 2003
Number of shared co-authors 4
Mitsuru Masaki
Division of Clinical Laboratory Medicine, Hyogo College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Eric J Velazquez
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 22
Lee R Goldberg
Hospital of the University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 9
Juan M Aranda
University of Florida
Career Start Year 1997
Number of shared co-authors 2
Naveen L Pereira
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 6
Peter A Brady
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 0
Rosario Rossi
University of Modena and Reggio Emilia, Policlinico di Modena
Career Start Year 1994
Number of shared co-authors 0
Euan A Ashley
Stanford University
Career Start Year 1993
Number of shared co-authors 6
Lori B Daniels
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 10
Peter A McCullough
Truth for Health Foundation
Career Start Year 1992
Number of shared co-authors 20
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 4
Ali Serdar Fak
Marmara University, Hypertension and Atherosclerosis Research Center
Career Start Year 1992
Number of shared co-authors 0
Mathieu Ghadanfar
Novartis Pharma AG
Career Start Year 1991
Number of shared co-authors 11
Vinay Thohan
Mission Hospital
Career Start Year 1989
Number of shared co-authors 14
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 8
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 19
Shawn W Robinson
University of Maryland
Career Start Year 1986
Number of shared co-authors 0
Serge Masson
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1986
Number of shared co-authors 10
Jalal K Ghali
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 18
Kent R Bailey
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 4
Francisco Fern??ndez-Avil??s
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 7
Paul Erne
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 6
Dimitrios Th Kremastinos
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 16
Robert O Bonow
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 30
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 21
Ezra A Amsterdam
University of California (Davis) Medical Center
Career Start Year 1961
Number of shared co-authors 18
Kurt Boman
Research Unit, Skelleftea County Hospital
Career Start Year 1949
Number of shared co-authors 2

Collaborators

John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 50
Barry M Massie
University of California at San Francisco
Co-authored papers 20
Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 18
Kenneth Dickstein
University of Bergen
Co-authored papers 12
Markku S Nieminen
Co-authored papers 11
Christian Hengstenberg
Co-authored papers 10
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 9
John R Teerlink
Cardiology University of California San Francisco (UCSF)
Co-authored papers 9
François Cambien
Co-authored papers 9
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 7
Alexandre Mebazaa
INSERM UMR-S , Universite de Paris Cite
Co-authored papers 7
Philippe Amouyel
Co-authored papers 6
Peter S Pang
Indiana University School of Medicine
Co-authored papers 6
Klaus Stark
Co-authored papers 5
Stuart A Cook
Co-authored papers 5
Renato D Lopes
Duke Clinical Research Institute, Duke University
Co-authored papers 4
Akshay S Desai
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 4
Adrian F Hernandez
Duke University Medical Center
Co-authored papers 4
Peter P Liu
Co-authored papers 4
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Co-authored papers 4
Elliott M Antman
Co-authored papers 4
Milton Packer
Co-authored papers 3
Jacques S Beckmann
University of Lausanne
Co-authored papers 3
Alexandra Durr
Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS
Co-authored papers 3
Julia B Lewis
Vanderbilt University Medical Center
Co-authored papers 3
Jean Weissenbach
Institut Francois Jacob, CNRS, Universite Paris-Saclay
Co-authored papers 3
Alexis Brice
Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS
Co-authored papers 3
Sanjay K Prasad
Co-authored papers 3
Christine E Seidman
Brigham and Women's Hospital (Y.K.
Co-authored papers 3
Christopher P Cannon
Brigham and Women's Hospital
Co-authored papers 3
Release 1.2